Effect of benzyl nicotinate on the percutaneous absorption of dexamethasone in the rat.
M A Kassem, K E Schulte
Index: Eur. J. Drug Metab. Pharmacokinet. 5(1) , 25-8, (1980)
Full Text: HTML
Abstract
The effect of benzyl nicotinate (15 mg) on the percutaneous absorption of dexamethasone 0,1 mg (62,5 uCi)/6 cm2, in an ethanol/octanol vehicle has been investigated in the rat. Both the urinary excretion and blood concentration data showed that benzyl nicotinate had a pronounced stimulating effect on the rate and extent of absorption. The relative bioavailability of dexamethasone was found to be 120% (urinary excretion data) or 146% (blood concentration data). Peak blood concentration increased greatly and was reached more quickly (1 1/2 hours instead of 2 1/2 hours).
Related Compounds
Related Articles:
2014-10-01
[Int. J. Cosmet. Sci. 36(5) , 412-8, (2014)]
1981-01-01
[Derm. Beruf Umwelt. 29(6) , 161-7, (1981)]
Kinetics of blood flow after topical application of benzyl nicotinate on different anatomic sites.
2006-11-01
[Arch. Dermatol. Res. 298(6) , 291-300, (2006)]
2003-01-01
[AAPS PharmSci 5(1) , E2, (2003)]
Estimation of serum protein binding of compounds metabolized in serum using matrix inhibition.
2008-07-01
[Biopharm. Drug Dispos. 29(5) , 308-10, (2008)]